AVANIR PHARMACEUTICALS INC's ticker is and the CUSIP is 05348P951. A total of 3 filers reported holding AVANIR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $11,223,000 | +66.0% | 662,100 | +16.7% | 0.17% | +62.5% |
| Q3 2014 | $6,762,000 | +374.5% | 567,300 | +124.5% | 0.10% | +372.7% |
| Q2 2014 | $1,425,000 | +86.8% | 252,700 | +21.6% | 0.02% | +69.2% |
| Q1 2014 | $763,000 | -43.5% | 207,800 | -48.3% | 0.01% | -35.0% |
| Q4 2013 | $1,351,000 | +23.5% | 402,000 | +55.9% | 0.02% | -4.8% |
| Q3 2013 | $1,094,000 | +1485.5% | 257,900 | +1607.9% | 0.02% | +950.0% |
| Q2 2013 | $69,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 662,100 | $11,223,000 | 0.17% |
| Citadel Advisors | 27,100 | $459,000 | 0.00% |
| SIMPLEX TRADING, LLC | 39 | $1,000 | 0.00% |